Feasibility and outcomes of kidney transplantation in patients with end‐stage kidney disease after haemopoietic stem cell transplantation

Documenti analoghi

• COVID‐19 outcomes in haemopoietic stem cell transplant recipients in Western Australia: the value of vaccination and antiviral therapy
  di: Jacques A. J. Malherbe, et al.
  Pubblicazione: (2024)
• Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern era
  di: Luani Barge, et al.
  Pubblicazione: (2025)
• Are we disadvantaging smokers by excluding them from kidney transplantation? A single‐centre experience and survey of kidney transplantation units
  di: Humam Hazim, et al.
  Pubblicazione: (2025)
• Safety, tolerability and efficacy of the use of tixagevimab/cilgavimab as pre‐exposure COVID‐19 prophylaxis in kidney and simultaneous pancreas kidney transplant recipients
  di: Wai H Lim, et al.
  Pubblicazione: (2025)
• Clearing the air: smoking status in kidney transplantation assessment – a question of risk or equity?
  di: Nasir Ali Shah, et al.
  Pubblicazione: (2025)